Domvanalimab
ARC-10
Phase 2 small_molecule active
Quick answer
Domvanalimab for Non Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Arcus Biosciences with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Non Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active